US Stock MarketDetailed Quotes

COCH Envoy Medical

Watchlist
  • 3.100
  • -0.010-0.32%
Close Sep 6 16:00 ET
60.76MMarket Cap-2031P/E (TTM)

Envoy Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
7.94%68K
-24.36%59K
33.33%316K
375.00%95K
40.35%80K
6.78%63K
78K
-23.55%237K
20K
57K
Operating revenue
7.94%68K
-24.36%59K
33.33%316K
375.00%95K
40.35%80K
6.78%63K
--78K
-23.55%237K
--20K
--57K
Cost of revenue
51.23%245K
-12.57%153K
58.43%789K
54.97%234K
78.30%189K
-25.69%162K
175K
-35.24%498K
151K
106K
Gross profit
-78.79%-177K
3.09%-94K
-81.23%-473K
-6.11%-139K
-122.45%-109K
37.74%-99K
-97K
43.14%-261K
-131K
-49K
Operating expense
6.89%4.68M
30.76%4.8M
111.94%17.9M
137.69%6.6M
87.52%3.28M
115.28%4.38M
3.67M
31.71%8.45M
2.78M
1.75M
Selling and administrative expenses
-6.10%2.09M
39.90%2.44M
157.69%8.94M
165.84%3.54M
75.62%1.43M
230.56%2.23M
--1.75M
40.32%3.47M
--1.33M
--812K
-Selling and marketing expense
29.77%497K
-12.40%325K
88.25%1.67M
----
----
--383K
--371K
--885K
----
----
-General and administrative expense
-13.55%1.6M
54.00%2.12M
181.47%7.28M
319.46%1.88M
75.62%1.43M
173.74%1.85M
--1.38M
4.53%2.59M
--447K
--812K
Research and development costs
20.34%2.59M
22.47%2.36M
80.02%8.96M
111.71%3.06M
97.86%1.85M
58.19%2.15M
--1.93M
26.30%4.98M
--1.44M
--935K
Operating profit
-8.48%-4.86M
-29.89%-4.9M
-111.02%-18.37M
-131.76%-6.74M
-88.47%-3.39M
-104.19%-4.48M
-3.77M
-26.71%-8.71M
-2.91M
-1.8M
Net non-operating interest income expense
-132K
-36K
0
0
Non-operating interest expense
--132K
--36K
----
----
----
--0
--0
----
----
----
Other net income (expense)
111.92%1.05M
85.91%-1.34M
-59.86%-11.54M
121.63%1.85M
982.71%4.95M
-1,015.03%-8.77M
-9.48M
-300.06%-7.22M
-8.57M
457K
Gain on sale of security
--1.05M
---1.34M
--1.72M
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
-83.62%-13.25M
101.62%139K
982.71%4.95M
-1,015.03%-8.77M
---9.48M
-300.06%-7.22M
---8.57M
--457K
Income before tax
70.20%-3.95M
52.69%-6.27M
-87.83%-29.91M
57.47%-4.88M
216.73%1.56M
-971.68%-13.25M
-13.25M
-83.55%-15.92M
-11.48M
-1.34M
Income tax
Net income
70.20%-3.95M
52.69%-6.27M
-87.83%-29.91M
57.47%-4.88M
216.73%1.56M
-971.68%-13.25M
-13.25M
-83.55%-15.92M
-11.48M
-1.34M
Net income continuous Operations
70.20%-3.95M
52.69%-6.27M
-87.83%-29.91M
57.47%-4.88M
216.73%1.56M
-971.68%-13.25M
---13.25M
-83.55%-15.92M
---11.48M
---1.34M
Minority interest income
Net income attributable to the parent company
70.20%-3.95M
52.69%-6.27M
-87.83%-29.91M
57.47%-4.88M
216.73%1.56M
-971.68%-13.25M
-13.25M
-83.55%-15.92M
-11.48M
-1.34M
Preferred stock dividends
1.37M
230K
Other preferred stock dividends
Net income attributable to common stockholders
59.90%-5.31M
52.69%-6.27M
-87.83%-29.91M
57.47%-4.88M
201.57%1.36M
-663.02%-13.25M
-13.25M
-49.16%-15.92M
-11.48M
-1.34M
Basic earnings per share
60.15%-0.27
75.34%-0.32
-51.76%-2.38
77.84%-0.249
153.07%0.0696
-298.65%-0.6775
-1.2975
-49.16%-1.5682
-1.1236
-0.1311
Diluted earnings per share
60.15%-0.27
75.34%-0.32
-51.76%-2.38
77.84%-0.249
153.07%0.0696
-298.65%-0.6775
-1.2975
-49.16%-1.5682
-1.1236
-0.1311
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 7.94%68K-24.36%59K33.33%316K375.00%95K40.35%80K6.78%63K78K-23.55%237K20K57K
Operating revenue 7.94%68K-24.36%59K33.33%316K375.00%95K40.35%80K6.78%63K--78K-23.55%237K--20K--57K
Cost of revenue 51.23%245K-12.57%153K58.43%789K54.97%234K78.30%189K-25.69%162K175K-35.24%498K151K106K
Gross profit -78.79%-177K3.09%-94K-81.23%-473K-6.11%-139K-122.45%-109K37.74%-99K-97K43.14%-261K-131K-49K
Operating expense 6.89%4.68M30.76%4.8M111.94%17.9M137.69%6.6M87.52%3.28M115.28%4.38M3.67M31.71%8.45M2.78M1.75M
Selling and administrative expenses -6.10%2.09M39.90%2.44M157.69%8.94M165.84%3.54M75.62%1.43M230.56%2.23M--1.75M40.32%3.47M--1.33M--812K
-Selling and marketing expense 29.77%497K-12.40%325K88.25%1.67M----------383K--371K--885K--------
-General and administrative expense -13.55%1.6M54.00%2.12M181.47%7.28M319.46%1.88M75.62%1.43M173.74%1.85M--1.38M4.53%2.59M--447K--812K
Research and development costs 20.34%2.59M22.47%2.36M80.02%8.96M111.71%3.06M97.86%1.85M58.19%2.15M--1.93M26.30%4.98M--1.44M--935K
Operating profit -8.48%-4.86M-29.89%-4.9M-111.02%-18.37M-131.76%-6.74M-88.47%-3.39M-104.19%-4.48M-3.77M-26.71%-8.71M-2.91M-1.8M
Net non-operating interest income expense -132K-36K00
Non-operating interest expense --132K--36K--------------0--0------------
Other net income (expense) 111.92%1.05M85.91%-1.34M-59.86%-11.54M121.63%1.85M982.71%4.95M-1,015.03%-8.77M-9.48M-300.06%-7.22M-8.57M457K
Gain on sale of security --1.05M---1.34M--1.72M----------------------------
Other non- operating income (expenses) ---------83.62%-13.25M101.62%139K982.71%4.95M-1,015.03%-8.77M---9.48M-300.06%-7.22M---8.57M--457K
Income before tax 70.20%-3.95M52.69%-6.27M-87.83%-29.91M57.47%-4.88M216.73%1.56M-971.68%-13.25M-13.25M-83.55%-15.92M-11.48M-1.34M
Income tax
Net income 70.20%-3.95M52.69%-6.27M-87.83%-29.91M57.47%-4.88M216.73%1.56M-971.68%-13.25M-13.25M-83.55%-15.92M-11.48M-1.34M
Net income continuous Operations 70.20%-3.95M52.69%-6.27M-87.83%-29.91M57.47%-4.88M216.73%1.56M-971.68%-13.25M---13.25M-83.55%-15.92M---11.48M---1.34M
Minority interest income
Net income attributable to the parent company 70.20%-3.95M52.69%-6.27M-87.83%-29.91M57.47%-4.88M216.73%1.56M-971.68%-13.25M-13.25M-83.55%-15.92M-11.48M-1.34M
Preferred stock dividends 1.37M230K
Other preferred stock dividends
Net income attributable to common stockholders 59.90%-5.31M52.69%-6.27M-87.83%-29.91M57.47%-4.88M201.57%1.36M-663.02%-13.25M-13.25M-49.16%-15.92M-11.48M-1.34M
Basic earnings per share 60.15%-0.2775.34%-0.32-51.76%-2.3877.84%-0.249153.07%0.0696-298.65%-0.6775-1.2975-49.16%-1.5682-1.1236-0.1311
Diluted earnings per share 60.15%-0.2775.34%-0.32-51.76%-2.3877.84%-0.249153.07%0.0696-298.65%-0.6775-1.2975-49.16%-1.5682-1.1236-0.1311
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg